Allworth Financial’s aTyr Pharma ATYR Stock Holding History

Allworth Financial’s Portfolio ATYR Stock Details ATYR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.16K	Buy	3,615 +3,249	+888%	+$2.12K	﹤0.01%	4485
2026 Q1	$286	Buy	+366	New	+$309	﹤0.01%	4861

Other funds holding ATYR

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $174M AUM

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Allworth Financial's ATYR Position: Q2 2026 in Review

Allworth Financial increased its aTyr Pharma (ATYR) stake by 888% in Q2 2026, buying an estimated $2.12K and bringing the position to 3,615 shares worth $2.16K. The position accounts for ﹤0.01% of the portfolio, ranked #4485.

Allworth Financial first reported a position in ATYR in Q1 2026 and has held it in 2 quarters since. 90 funds tracked by Wall St. Rank hold ATYR as of Q2 2026.

Allworth Financial held 3,615 shares of aTyr Pharma worth $2.16K as of Q2 2026.
Allworth Financial bought 3,249 aTyr Pharma shares in Q2 2026, an estimated $2.12K.
aTyr Pharma made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #4485 holding.
Allworth Financial first reported a position in aTyr Pharma in Q1 2026 and has held it in 2 quarters since.
90 funds tracked by Wall St. Rank held aTyr Pharma as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.